financetom
Market
financetom
/
Market
/
Chinese AI Platform Fuels Jitters on Wall Street, Driving Premarket Losses for US Equity Futures
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chinese AI Platform Fuels Jitters on Wall Street, Driving Premarket Losses for US Equity Futures
Jan 27, 2025 6:25 AM

09:03 AM EST, 01/27/2025 (MT Newswires) -- US equity futures dropped ahead of Monday's opening bell, with futures of the technology-heavy Nasdaq Composite leading the losses amid concerns surrounding the artificial intelligence sector.

Dow Jones Industrial Average futures fell 0.7%, S&P 500 futures dropped 2%, and Nasdaq futures were down 3.5%.

Nvidia ( NVDA ) and other artificial intelligence players were sharply lower after the rapid rise of Chinese artificial intelligence startup DeepSeek, which launched an open-source artificial intelligence model that can potentially run on less-advanced chips.

Oil prices were lower, with front-month global benchmark North Sea Brent crude down 0.7% at $77.00 per barrel and US West Texas Intermediate 0.7% lower at $74.11 per barrel.

New home sales, scheduled for release at 10 am ET, are expected to have risen to a 669,000 annual rate in December from 664,000 in the preceding month.

In other world markets, Japan's Nikkei closed 0.9% lower, Hong Kong's Hang Seng ended 0.7% higher, and China's Shanghai Composite finished 0.06% lower. Meanwhile, the UK's FTSE 100 fell 0.2%, and Germany's Dax index dropped 0.8% in Europe's early afternoon session.

In equities, Nvidia ( NVDA ) shares fell 12% pre-bell, while ASML ( ASML ) , Advanced Micro Devices ( AMD ) , Broadcom ( AVGO ) , and Micron Technology ( MU ) were also down between 4% to 10% amid the DeepSeek threat. Microsoft ( MSFT ) shares fell 4% after Reuters reported that more Indian news outlets joined a copyright lawsuit against OpenAI.

On the winning side, Aurora Mobile ( JG ) shares were up over 170% after the company said its business-oriented AI agent platform GPTBots.ai has integrated the DeepSeek R1 large language model. Akero Therapeutics ( AKRO ) stock increased more than two-fold after the company said its phase 2b trial of a drug candidate for biopsy-confirmed compensated cirrhosis showed "statistically significant" preliminary results.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved